Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.

Suppr

超能文献

作者信息

Joffe B I, Kew M C, Panz V R, Kalk W J, Shires R, Wing J, Seftel H C

机构信息

Department of Medicine, University of the Witwatersrand Medical School, Parktown, Johannesburg, South Africa.

出版信息

Br J Cancer. 1988 Jul;58(1):91-2. doi: 10.1038/bjc.1988.170.

DOI:10.1038/bjc.1988.170

PMID:2844221

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2246484/

Abstract

摘要

相似文献

Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.

Br J Cancer. 1988 Jul;58(1):91-2. doi: 10.1038/bjc.1988.170.

[Hypoglycemia and primary liver cancer. Hormone levels. Action of diazoxide].

Rev Med Chir Mal Foie. 1967 Jun;42(3):157-66.

Paraneoplastic hypoglycaemia treated with somatostatin analogue SMS 201-995.

Eur J Surg Oncol. 1996 Oct;22(5):546-7. doi: 10.1016/s0748-7983(96)93317-x.

[Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].

Ned Tijdschr Geneeskd. 2002 May 4;146(18):859-62.

Studies on hypoglycaemia in primary carcinoma of the liver. A case report and review of pathogenetic mechanisms.

S Afr Med J. 1974 Mar 31;47(12):518-24.

[Hypoglycemia and primary cancer of the liver. Hormonal titers. Action of diazoxide].

Bull Mem Soc Med Hop Paris. 1967 Jan 27;118(2):131-8.

Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon.

Clin Endocrinol (Oxf). 1995 Jul;43(1):117-20; discussion 120-2. doi: 10.1111/j.1365-2265.1995.tb01901.x.

Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.

S Afr Med J. 1988 Jul 16;74(2):75-6.

Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors.

Liver. 1992 Apr;12(2):90-3. doi: 10.1111/j.1600-0676.1992.tb00563.x.

Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.

Gut. 2002 Jul;51(1):100-4. doi: 10.1136/gut.51.1.100.

本文引用的文献

Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

J Clin Invest. 1981 Nov;68(5):1321-30. doi: 10.1172/jci110379.

Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia.

J Clin Endocrinol Metab. 1981 Aug;53(2):289-94. doi: 10.1210/jcem-53-2-289.

The riddle of tumour hypoglycaemia revisited.

Clin Endocrinol Metab. 1980 Jul;9(2):335-60. doi: 10.1016/s0300-595x(80)80037-5.

Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors.

N Engl J Med. 1981 Dec 10;305(24):1452-5. doi: 10.1056/NEJM198112103052405.

SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Life Sci. 1982 Sep 13;31(11):1133-40. doi: 10.1016/0024-3205(82)90087-x.

Further observations on hypoglycaemia in hepatocellular carcinoma.

Am J Med. 1969 Aug;47(2):220-35. doi: 10.1016/0002-9343(69)90148-x.

Tumor hypoglycemia: deficient splanchnic glucose output and deficient glucagon secretion.

Diabetes. 1976 Mar;25(3):202-6. doi: 10.2337/diab.25.3.202.

Serum somatomedin and insulin levels in tumor hypoglycemia.

J Endocrinol Invest. 1978 Jul;1(3):269-71. doi: 10.1007/BF03350392.

Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.

Lancet. 1979 Oct 13;2(8146):764-7. doi: 10.1016/s0140-6736(79)92115-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验